Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Verastem (VSTM) EBITDA (2018 - 2025)

Verastem has reported EBITDA over the past 8 years, most recently at -$25.1 million for Q4 2025.

  • Quarterly results put EBITDA at -$25.1 million for Q4 2025, up 61.05% from a year ago — trailing twelve months through Dec 2025 was -$191.0 million (down 46.16% YoY), and the annual figure for FY2025 was -$204.2 million, down 56.33%.
  • EBITDA for Q4 2025 was -$25.1 million at Verastem, up from -$95.8 million in the prior quarter.
  • Over the last five years, EBITDA for VSTM hit a ceiling of -$8.3 million in Q2 2024 and a floor of -$95.8 million in Q3 2025.
  • Median EBITDA over the past 5 years was -$22.4 million (2021), compared with a mean of -$27.7 million.
  • Biggest five-year swings in EBITDA: surged 66.02% in 2024 and later plummeted 299.6% in 2025.
  • Verastem's EBITDA stood at -$16.5 million in 2021, then fell by 1.79% to -$16.8 million in 2022, then crashed by 63.42% to -$27.4 million in 2023, then plummeted by 135.55% to -$64.6 million in 2024, then soared by 61.05% to -$25.1 million in 2025.
  • The last three reported values for EBITDA were -$25.1 million (Q4 2025), -$95.8 million (Q3 2025), and -$24.6 million (Q2 2025) per Business Quant data.